Financhill
Back

CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings

CRISPR Therapeutics AG Price Quote

$48.78
-1.01 (-2.03%)
(Updated: November 14, 2024 at 12:25 PM ET)

CRISPR Therapeutics AG Key Stats

Buy
61
CRISPR Therapeutics AG (CRSP) is a Buy

Day range:
$49.41 - $52.43
52-week range:
$43.42 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.23%

Volume:
1.9M
Avg. volume:
1.4M
1-year change:
-4.27%
Market cap:
$4.3B
Revenue:
$370M
EPS:
$-2.8

How Much Does CRISPR Therapeutics AG Make?

Data Unavailable

Is CRISPR Therapeutics AG Growing As A Company?

Data Unavailable

CRISPR Therapeutics AG Stock Price Performance

What Is CRISPR Therapeutics AG 52-Week High & Low?

CRISPR Therapeutics AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CRISPR Therapeutics AG?

Is CRISPR Therapeutics AG Cash Flow Positive?

  • What Is CRSP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$188.8M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $354M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$467.8M

CRISPR Therapeutics AG Return On Invested Capital

Data Unavailable

CRISPR Therapeutics AG Earnings Date & Stock Price

CRISPR Therapeutics AG Competitors

CRISPR Therapeutics AG Dividend Yield

CRISPR Therapeutics AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.11%
Revenue: 0% -91.56%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 11
Sell Recommendations: 2
Price Target: 81.54
Upside from Last Price: 63.77%

Major Shareholders

  • How many CRSP shares are owned by institutional investors?
    98.4M CRSP shares are owned by institutional investors
  • How many CRSP shares are owned by insiders?
    1.6M CRSP shares are owned by insiders